A new study shows risks for premature death associated with CUD. Others show increased memory problems, CUD, depression, ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...

Cannabis is gaining widespread appeal and a growing number of U.S. states are approving medical marijuana. A large study ...

Although surveys have found that few clinicians discuss cannabis use with their patients, experts make the case why they ...

From 2014 to 2022, the number of psychiatrists billing Medicare Part B declined, while the total number of active ...

A new cohort study found that schizophrenia cases related to cannabis use disorder serious enough to warrant a person to seek emergency care increased afte ...

The Food and Drug Administration (FDA) has granted Fast Track designation to PP-01 (nabilone/gabapentin) for the mitigation of cannabis withdrawal ...

A new effort is underway to legalize not just medical marijuana but recreational use, too. But is that the best route forward ...

Recent health news covers various topics: a new mpox case in New York, promising results of Ozempic for alcohol use disorder, U.S. impact on global health funding, Robert F. Kennedy Jr.'s health ...

Chronic health conditions are having a serious, negative impact on the welfare of the country's workers and their output, a ...